CLINICAL_TRIALS
research
· 2025-12-05
Clinical Trial Update: Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation [Phase 2]
Summary
A Phase 2 randomized trial (AP31969 vs placebo) for rhythm control in atrial fibrillation is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Acesion Pharma | Conditions: Atrial Fibrillation (AF) | Phase 2 | Status: RECRUITING